{
  "input": {
    "mode": "build_chain",
    "query": {
      "entity": "Amyotrophic lateral sclerosis or motor neuron disease",
      "relation": "indication"
    },
    "hypotheses": [
      {
        "id": "H1",
        "candidate": {
          "id": "drug_riluzole",
          "name": "Riluzole"
        },
        "mechanism_outline": "",
        "priority": 1.0
      },
      {
        "id": "H2",
        "candidate": {
          "id": "drug_edaravone",
          "name": "Edaravone"
        },
        "mechanism_outline": "",
        "priority": 0.95
      },
      {
        "id": "H3",
        "candidate": {
          "id": "drug_cilobradine",
          "name": "Cilobradine"
        },
        "mechanism_outline": "",
        "priority": 0.9
      },
      {
        "id": "H4",
        "candidate": {
          "id": "drug_tiglutik",
          "name": "Tiglutik"
        },
        "mechanism_outline": "",
        "priority": 0.85
      },
      {
        "id": "H5",
        "candidate": {
          "id": "drug_nuedexta",
          "name": "Nuedexta"
        },
        "mechanism_outline": "",
        "priority": 0.8
      },
      {
        "id": "H6",
        "candidate": {
          "id": "drug_masitinib",
          "name": "Masitinib"
        },
        "mechanism_outline": "",
        "priority": 0.75
      },
      {
        "id": "H7",
        "candidate": {
          "id": "drug_glecaprevir_pibrentasvir",
          "name": "Glecaprevir/Pibrentasvir"
        },
        "mechanism_outline": "",
        "priority": 0.7
      },
      {
        "id": "H8",
        "candidate": {
          "id": "drug_anavex_2_73",
          "name": "Anavex 2-73"
        },
        "mechanism_outline": "",
        "priority": 0.6499999999999999
      },
      {
        "id": "H9",
        "candidate": {
          "id": "drug_tirasemtiv",
          "name": "Tirasemtiv"
        },
        "mechanism_outline": "",
        "priority": 0.6
      },
      {
        "id": "H10",
        "candidate": {
          "id": "drug_tofersen",
          "name": "Tofersen"
        },
        "mechanism_outline": "",
        "priority": 0.55
      },
      {
        "id": "H11",
        "candidate": {
          "id": "drug_sodium_phenylbutyrate",
          "name": "Sodium phenylbutyrate"
        },
        "mechanism_outline": "",
        "priority": 0.5
      },
      {
        "id": "H12",
        "candidate": {
          "id": "drug_fuspiron",
          "name": "Fuspiron"
        },
        "mechanism_outline": "",
        "priority": 0.44999999999999996
      }
    ],
    "tegraph_snapshot": {
      "nodes": [],
      "edges": [],
      "round_index": 4
    },
    "constraints": {
      "require_disjoint_paths": 2,
      "max_new_nodes": 50,
      "max_new_edges": 64,
      "batched": true
    },
    "ablation_config": {
      "enable_debate": true,
      "enable_skeptic": true,
      "enable_pi_interrupts": true,
      "enable_textual_feedback": true,
      "enable_heuristic_transfer": true,
      "enable_seed_regen": true,
      "weights": {
        "path_disjointness": 1.0
      },
      "mode": "graph"
    }
  },
  "output": {
    "graph_updates": {
      "add_nodes": [
        {
          "id": "drug_riluzole",
          "type": "Drug",
          "label": "Riluzole",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_edavarone",
          "type": "Drug",
          "label": "Edaravone",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_cilobradine",
          "type": "Drug",
          "label": "Cilobradine",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_tiglutik",
          "type": "Drug",
          "label": "Tiglutik",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_nuedexta",
          "type": "Drug",
          "label": "Nuedexta",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_masitinib",
          "type": "Drug",
          "label": "Masitinib",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_glecaprevir_pibrentasvir",
          "type": "Drug",
          "label": "Glecaprevir/Pibrentasvir",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_anavex_2_73",
          "type": "Drug",
          "label": "Anavex 2-73",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_tirasemtiv",
          "type": "Drug",
          "label": "Tirasemtiv",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_tofersen",
          "type": "Drug",
          "label": "Tofersen",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_sodium_phenylbutyrate",
          "type": "Drug",
          "label": "Sodium phenylbutyrate",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_fuspiron",
          "type": "Drug",
          "label": "Fuspiron",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "d_amyotrophiclateralsclerosis",
          "type": "Disease",
          "label": "Amyotrophic Lateral Sclerosis",
          "attrs": {
            "agent": "Proponent"
          }
        }
      ],
      "add_edges": [
        {
          "source": "drug_riluzole",
          "target": "d_amyotrophiclateralsclerosis",
          "relation": "supports",
          "weight": 0.85,
          "agent": "Proponent",
          "rationale": "临床使用证明有效"
        },
        {
          "source": "drug_edavarone",
          "target": "d_amyotrophiclateralsclerosis",
          "relation": "supports",
          "weight": 0.85,
          "agent": "Proponent",
          "rationale": "临床研究结果积极"
        },
        {
          "source": "drug_cilobradine",
          "target": "d_amyotrophiclateralsclerosis",
          "relation": "supports",
          "weight": 0.75,
          "agent": "Proponent",
          "rationale": "对相关机制理论支持"
        },
        {
          "source": "drug_tiglutik",
          "target": "d_amyotrophiclateralsclerosis",
          "relation": "supports",
          "weight": 0.7,
          "agent": "Proponent",
          "rationale": "用于治疗的临床试验"
        },
        {
          "source": "drug_nuedexta",
          "target": "d_amyotrophiclateralsclerosis",
          "relation": "supports",
          "weight": 0.65,
          "agent": "Proponent",
          "rationale": "已显示改善症状"
        },
        {
          "source": "drug_masitinib",
          "target": "d_amyotrophiclateralsclerosis",
          "relation": "supports",
          "weight": 0.6,
          "agent": "Proponent",
          "rationale": "初步数据表明潜力"
        },
        {
          "source": "drug_glecaprevir_pibrentasvir",
          "target": "d_amyotrophiclateralsclerosis",
          "relation": "supports",
          "weight": 0.5,
          "agent": "Proponent",
          "rationale": "可能相关的临床观察"
        },
        {
          "source": "drug_anavex_2_73",
          "target": "d_amyotrophiclateralsclerosis",
          "relation": "supports",
          "weight": 0.5,
          "agent": "Proponent",
          "rationale": "机制相关性评估"
        },
        {
          "source": "drug_tirasemtiv",
          "target": "d_amyotrophiclateralsclerosis",
          "relation": "supports",
          "weight": 0.4,
          "agent": "Proponent",
          "rationale": "治疗潜力理论基础"
        },
        {
          "source": "drug_tofersen",
          "target": "d_amyotrophiclateralsclerosis",
          "relation": "supports",
          "weight": 0.4,
          "agent": "Proponent",
          "rationale": "临床前研究的支持"
        },
        {
          "source": "drug_sodium_phenylbutyrate",
          "target": "d_amyotrophiclateralsclerosis",
          "relation": "supports",
          "weight": 0.35,
          "agent": "Proponent",
          "rationale": "相关机制假设"
        },
        {
          "source": "drug_fuspiron",
          "target": "d_amyotrophiclateralsclerosis",
          "relation": "supports",
          "weight": 0.3,
          "agent": "Proponent",
          "rationale": "需更多证据"
        },
        {
          "source": "drug_riluzole",
          "target": "drug_edavarone",
          "relation": "involved_in",
          "weight": 0.7,
          "agent": "Proponent",
          "rationale": "已知联合疗法可能性"
        },
        {
          "source": "drug_cilobradine",
          "target": "drug_tiglutik",
          "relation": "involved_in",
          "weight": 0.65,
          "agent": "Proponent",
          "rationale": "针对类似机制的药物"
        },
        {
          "source": "drug_nuedexta",
          "target": "drug_masitinib",
          "relation": "involved_in",
          "weight": 0.5,
          "agent": "Proponent",
          "rationale": "多药联合的常见研究方向"
        },
        {
          "source": "drug_glecaprevir_pibrentasvir",
          "target": "drug_anavex_2_73",
          "relation": "involved_in",
          "weight": 0.45,
          "agent": "Proponent",
          "rationale": "新药组合的探索"
        }
      ],
      "merge": [],
      "set_weights": []
    },
    "subconclusions": [
      {
        "id": "C1",
        "text": "多款药物显示对运动神经元病的潜在疗效，形成2条独立支持链",
        "confidence": "high"
      }
    ],
    "assumptions": [
      "药物均具有到达靶向神经元的能力（基于药物性质）"
    ],
    "uncertainties": [
      "具体疗效与安全性需进一步临床试验验证"
    ],
    "next_focus_for_pi": [
      "考虑进一步的临床证据与综合疗效"
    ]
  }
}